These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3900467)

  • 1. [Toxic hepatitis induced by antibiotics].
    Kunii O
    Nihon Rinsho; 1985 Jun; 43(6):1155-60. PubMed ID: 3900467
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962.
    Gilbert FI
    Hawaii Med J; 1995 Jun; 54(6):603-5. PubMed ID: 7642362
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatotoxicity of antimicrobial agents. I: Antibacterial antibiotics].
    Horsmans Y; Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1990; 14(12):911-8. PubMed ID: 1963160
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cholestatic hepatitis caused by erythromycin estolate].
    García Monzón C; Noguerado A; Hidalgo S; Escudero V
    Rev Clin Esp; 1985 Nov; 177(8):420-1. PubMed ID: 3836470
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythromycin estolate-induced hepatitis. Ultrastructural study of liver.
    Gafter U; Mandel EM; Weiss S; Djaldetti M
    N Y State J Med; 1979 Jan; 79(1):87-9. PubMed ID: 282477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephrotoxicity of antibiotics].
    Triolo R
    Minerva Med; 1976 May; 67(23):1500-10. PubMed ID: 934504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis caused by drugs. 4].
    Valerdiz Casasola S; Linares Rodríguez A; Recarte Alvarez J; Rodrigo Sáez L
    Rev Esp Enferm Apar Dig; 1982 Oct; 62(4):332-41. PubMed ID: 7163594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxic hepatitis (liver and antitubercular drugs)].
    Kohan S
    Acta Gastroenterol Latinoam; 1977 Dec; 7(4):301-4. PubMed ID: 617560
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA begins proceedings to remove erythromycin estolate from market.
    FDA Drug Bull; 1979 Nov; 9(5):26-7. PubMed ID: 510836
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis from isoniazid and rifampin.
    Groopman JE; Soloff L; Tessler S
    N Engl J Med; 1978 Jun; 298(23):1316-7. PubMed ID: 651986
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug interactions and hepatitis produced by some macrolide antibiotics.
    Pessayre D; Larrey D; Funck-Brentano C; Benhamou JP
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():181-94. PubMed ID: 3877043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythromycin-induced hepatitis].
    Perrier M; Portier G; de Calan L; Favre JP; Ozoux JP; Rivallain B; Brizon J
    Cah Anesthesiol; 1987; 35(3):237. PubMed ID: 3621021
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk-benefit equation for erythromycin estolate.
    LeBel M
    Am J Hosp Pharm; 1980 Feb; 37(2):176, 180. PubMed ID: 7361788
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis caused by various derivatives of erythromycin].
    Funck-Brentano C; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Apr; 7(4):362-9. PubMed ID: 6347792
    [No Abstract]   [Full Text] [Related]  

  • 15. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
    Steele MA; Burk RF; DesPrez RM
    Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929
    [No Abstract]   [Full Text] [Related]  

  • 17. Ilosone update.
    Culp ER
    Am Fam Physician; 1980 Apr; 21(4):23. PubMed ID: 7377065
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines.
    Carson JL; Strom BL; Duff A; Gupta A; Shaw M; Lundin FE; Das K
    Ann Intern Med; 1993 Oct; 119(7 Pt 1):576-83. PubMed ID: 8363168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis and antitubercular therapy.
    Mahashur AA; Prabhudesai PP
    J Assoc Physicians India; 1991 Aug; 39(8):595-6. PubMed ID: 1814871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.